Hyperfine (HYPR) announced it has received CE Marking and UK Conformity Assessment approval for its Optive AI software. These approvals, which closely follow the FDA clearance, deliver a substantial leap in image quality for the Swoop portable MRI system and expand international access to the latest Hyperfine AI-powered imaging software. Together, they mark a pivotal step in the company’s ongoing commercial expansion across international markets.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR: